Evgenios Koumantakis

No ORCID on file · 7 papers in corpus
nonrandomized-trial 2004
International journal of fertility and women's medicine

OBJECTIVE: To investigate the effects of danazol and leuprorelin acetate on CA-125 levels during treatment for endometriosis. PATIENTS AND METHODS: Fifty women with laparoscopically diagnosed and treated endometriosis, and 50 women without…

rct 2001
Journal of Reproductive Immunology ·doi:10.1016/s0165-0378(01)00064-x

Adhesion molecules regulate the interaction of cells with the extracellular matrix and/or other cells. The intercellular adhesion molecule-1 (ICAM-1; CD54) is a member of the immunoglobulin superfamily and expressed by several cell types, i…

2001
·doi:10.1163/156856001760209798
other 2001
Mediators of inflammation ·doi:10.1080/09629350120054545

BACKGROUND: Endometriosis is defined as an inflammatory condition of the female reproductive tract, a state often associated with infertility and miscarriage. Many exogenously administered factors (treatments) control the disease via as yet…

rct 2000
·doi:10.1097/00006250-200006000-00006

In Brief Objective To determine the effects of treatment with danazol and leuprolide acetate depot on serum-soluble CD23 concentrations in women with endometriosis. Methods This randomized trial involved 20 women 18–42 years old with regula…

nonrandomized-trial 2000
American journal of obstetrics and gynecology ·doi:10.1067/mob.2000.105900

OBJECTIVE: This study was undertaken to evaluate serum leptin concentrations in women with endometriosis during treatment with danazol and with leuprolide depot. STUDY DESIGN: Twenty patients aged 18 to 42 years with regular menses and doc…

case-report 2000
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(00)00245-1

A 37-year old woman presented with severe endometriosis and the patient underwent a conservative operation. We investigated the effect of treatment with danazol on the levels of CA-125, CA-19-9, CA 15-3, SIL-2R, IL-6, IL-1a, TNE-a, SCD8 and…